Development of an oral treatment with the PPAR-γ-acting cannabinoid VCE-003.2 against the inflammation-driven neuronal deterioration in experimental Parkinson’s disease
Zeitschrift:
Molecules
ISSN: 1420-3049
Datum der Publikation: 2019
Ausgabe: 24
Nummer: 15
Art: Artikel